ArticleGels (Basel, Switzerland)2025
Fabrication and Properties of Chitosan/Calcium Polyphosphate Fibre Composite Biological Scaffold.
Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Natural biomaterials are widely used in the construction of cartilage tissue engineering due to their excellent biocompatibility, easy degradation, and ability to degrade products to be absorbed by the human body. However, due to their poor mechanical properties, it is usually necessary to composite them with other materials to prepare biological scaffolds that meet the expected requirements. This study used freeze-drying technology to introduce calcium polyphosphate fibres (CPPFs) into a chitosan (CS) matrix to prepare composite scaffolds with better performance. CPPF was used as a filler and inorganic skeleton in the CS/CPPF composite to improve the properties of the CS-based scaffold. With little change in porosity, the compressive strength of the CS/CPPF composite scaffold increased from 0.172 MPa of chitosan to 0.332 MPa with the increase in CPPF addition. The water absorption rate of the composite scaffold decreased from 1297.42% to 935.37%. In vitro degradation experiments revealed that CPPF accelerated the degradation of the scaffold and generated calcium phosphate and nano-hydroxyapatite compounds during the degradation process. According to our cytotoxicity testing, the CS/CPPF composite scaffolds exhibited good biocompatibility and could enhance cell proliferation. This method of incorporating CPPF into CS provides important reference values for the application of CPPF in other natural bone tissue engineering scaffold materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.